Table 3.

Comparative costs of other common healthcare treatments (analysis of guidance of the National Institute for Clinical Excellence)

	Incremental cost (£)
Intervention	Per quality adjusted life year	Per life year gained
Zanamivir in managing influenza	9300-31 500
Taxanes for ovarian cancer		6500-10 000
Taxanes for breast cancer		7000-24 000
Implantable cardioverter defibrillators for arrhythmias		26 000-31 000
Glycoprotein IIb/IIIa inhibitors for acute coronary syndromes		7000-12 000
Methylphenidate for attention-deficit/hyperactivity disorder in children	10 000-15 000
Tribavirin and interferon alfa for hepatitis C:
First six months' treatment	3000-7000
Second six months' treatment	5000-36 000
Laparoscopic surgery for inguinal hernias	50 000
Riluzole for motor neurone disease	34 000-43 000
Orlistat for obesity in adults		20 000-30 000

Adapted from Raftery (BMJ 2001;323: 1300-3).